These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 32383245)

  • 1. Evaluating the mechanism underlying antitumor effect of interleukin 27 on B cells of chronic lymphocytic leukemia patients.
    Manouchehri-Doulabi E; Abbaspour S; Rostami S; Faranoush M; Ghahramanfard F; Pak F; Barati M; Kokhaei P; Momtazi-Borojeni AA
    J Cell Physiol; 2020 Dec; 235(12):9424-9431. PubMed ID: 32383245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of IL-4 level by fludarabine and its relation to apoptosis in chronic B-cell lymphocytic leukemia.
    Shamaa LA; Hussein Ael-S; Balbaa OA; Farahat NM; Ali MA
    Egypt J Immunol; 2008; 15(1):181-92. PubMed ID: 20306682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chrysin induces apoptosis in peripheral blood lymphocytes isolated from human chronic lymphocytic leukemia.
    Zaric M; Mitrovic M; Nikolic I; Baskic D; Popovic S; Djurdjevic P; Milosavljevic Z; Zelen I
    Anticancer Agents Med Chem; 2015; 15(2):189-95. PubMed ID: 25257897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B-CLL cells acquire APC- and CTL-like phenotypic characteristics after stimulation with CpG ODN and IL-21.
    Hagn M; Blackwell SE; Beyer T; Ebel V; Fabricius D; Lindner S; Stilgenbauer S; Simmet T; Tam C; Neeson P; Trapani JA; Schrezenmeier H; Weiner GJ; Jahrsdörfer B
    Int Immunol; 2014 Jul; 26(7):383-95. PubMed ID: 24497611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine modulation of nuclear factor-kappaB activity in B-chronic lymphocytic leukemia.
    Zaninoni A; Imperiali FG; Pasquini C; Zanella A; Barcellini W
    Exp Hematol; 2003 Mar; 31(3):185-90. PubMed ID: 12644014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic induction of apoptosis in B-cell chronic lymphocytic leukemia cells after treatment with all-trans retinoic acid in combination with interleukin-21 and rituximab.
    Abbaszadeh-Goudarzi K; Shokri F; Hosseini M; Jadidi-Niaragh F; Ghalamfarsa G; Saboor-Yaraghi AA
    J Cancer Res Ther; 2016; 12(4):1278-1283. PubMed ID: 28169240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-25 Impact on Malignant B Cells Survival and T Cells Activation in Chronic Lymphocytic Leukemia.
    Pashei M; Ghahremanfard F; Manouchehri Doulabi E; Hemmati M; Pak F; Kokhaei P
    Iran J Allergy Asthma Immunol; 2023 Jun; 22(3):299-311. PubMed ID: 37524666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-21 and rituximab enhance NK cell functionality in patients with B-cell chronic lymphocytic leukaemia.
    Eskelund CW; Nederby L; Thysen AH; Skovbo A; Roug AS; Hokland ME
    Leuk Res; 2011 Jul; 35(7):914-20. PubMed ID: 21354618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-13 inhibits interleukin-2-induced proliferation and protects chronic lymphocytic leukemia B cells from in vitro apoptosis.
    Chaouchi N; Wallon C; Goujard C; Tertian G; Rudent A; Caput D; Ferrera P; Minty A; Vazquez A; Delfraissy JF
    Blood; 1996 Feb; 87(3):1022-9. PubMed ID: 8562926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Preparation of heat shock protein 70 (Hsp70) and idiotypic determinant single-chain antibody (Id-ScFv) in a patient with B-cell chronic lymphatic leukemia (B-CLL) and antitumor effect of peptide complex Hsp70-Id].
    Ye Q; Wang ZH; Qin SK
    Ai Zheng; 2008 Feb; 27(2):133-8. PubMed ID: 18279608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. All-trans-retinoic Acid differentially regulates proliferation of normal and leukemic B cells from different subsets of chronic lymphocytic leukemia.
    Ghalamfarsa G; Jadidi-Niaragh F; Amiri MM; Razavi SM; Saboor-Yaraghi AA; Shokri F
    Nutr Cancer; 2015; 67(2):285-91. PubMed ID: 25611428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-15 promotes the growth of leukemic cells of patients with B-cell chronic lymphoproliferative disorders.
    Trentin L; Cerutti A; Zambello R; Sancretta R; Tassinari C; Facco M; Adami F; Rodeghiero F; Agostini C; Semenzato G
    Blood; 1996 Apr; 87(8):3327-35. PubMed ID: 8605349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of apoptosis with cytokines in B-cell chronic lymphocytic leukaemia.
    Mainou-Fowler T; Prentice AG
    Leuk Lymphoma; 1996 May; 21(5-6):369-77. PubMed ID: 9172801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of interleukins on the proliferation and survival of B cell chronic lymphocytic leukaemia cells.
    Mainou-Fowler T; Copplestone JA; Prentice AG
    J Clin Pathol; 1995 May; 48(5):482-7. PubMed ID: 7629299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant human IL-15 trans-presentation by B leukemic cells from chronic lymphocytic leukemia induces autologous NK cell proliferation leading to improved anti-CD20 immunotherapy.
    Laprevotte E; Voisin G; Ysebaert L; Klein C; Daugrois C; Laurent G; Fournie JJ; Quillet-Mary A
    J Immunol; 2013 Oct; 191(7):3634-40. PubMed ID: 23997218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal Expression of BTLA and CTLA-4 Immune Checkpoint Molecules in Chronic Lymphocytic Leukemia Patients.
    Karabon L; Partyka A; Ciszak L; Pawlak-Adamska E; Tomkiewicz A; Bojarska-Junak A; Roliński J; Wołowiec D; Wrobel T; Frydecka I; Kosmaczewska A
    J Immunol Res; 2020; 2020():6545921. PubMed ID: 32775467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of apoptosis by cytokines in B-cell chronic lymphocytic leukemia.
    Castejón R; Vargas JA; Romero Y; Briz M; Muñoz RM; Durántez A
    Cytometry; 1999 Oct; 38(5):224-30. PubMed ID: 10516608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type 4 cyclic adenosine monophosphate phosphodiesterase as a therapeutic target in chronic lymphocytic leukemia.
    Kim DH; Lerner A
    Blood; 1998 Oct; 92(7):2484-94. PubMed ID: 9746789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-malignant leukocytes delay spontaneous B-CLL cell apoptosis.
    Gamberale R; Geffner J; Arrosagaray G; Scolnik M; Salamone G; Trevani A; Vermeulen M; Giordano M
    Leukemia; 2001 Dec; 15(12):1860-7. PubMed ID: 11753606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lenalidomide induces immunomodulation in chronic lymphocytic leukemia and enhances antitumor immune responses mediated by NK and CD4 T cells.
    Acebes-Huerta A; Huergo-Zapico L; Gonzalez-Rodriguez AP; Fernandez-Guizan A; Payer AR; López-Soto A; Gonzalez S
    Biomed Res Int; 2014; 2014():265840. PubMed ID: 25313353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.